The Kavli Prize in Nanoscience, given every other year by the Norwegian Academy of Science and Letters and the Kavli Foundation, was awarded this year to Jennifer Doudna, a faculty biochemist in the Molecular Biophysics and Integrated Bioimaging (MBIB) Division, and two colleagues who developed the powerful nanoscale tool CRISPR-Cas9 to edit DNA. The $1 million award, announced May 31, will be shared by Doudna, an HHMI investigator and professor of molecular and cell biology and of chemistry at UC Berkeley, Emmanuelle Charpentier of the Max Planck Society, and Virginijus Šikšnys of the Institute of Applied Enzymology in Vilnius, Lithuania. The 2018 Kavli Prizes will be awarded on September 4 in Oslo, Norway. “This prize recognizes the profound value of curiosity-driven research, and represents the contributions of our lab members. It’s an honor to share The Kavli Prize with my colleagues,” Doudna said. Read the UC Berkeley news release.